Nonhistaminergic idiopathic angioedema: Clinical response to icatibant

Journal of Investigational Allergology and Clinical Immunology

Volumn 22, Issue 7, 2012, Pages 520-521

  Colas, C ^a,c   Montoiro, R ^a   Fraj, J ^a   Garces M ^a   Cubero, Jl ^b  

^a HOSPITAL CLÍNICO UNIVERSITARIO LOZANO BLESA   (Spain)

^b HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

^c Biomedical Research Network on Rare Diseases U754 ^*  (Spain)

Author keywords

Angioedema; Bradykinin; Icatibant; Laryngeal edema

Indexed keywords

ADRENALIN; ANTIHISTAMINIC AGENT; COMPLEMENT COMPONENT C1Q; COMPLEMENT COMPONENT C1S INHIBITOR; COMPLEMENT COMPONENT C3; COMPLEMENT COMPONENT C4; CORTICOSTEROID; DAPSONE; DEXCHLORPHENIRAMINE; HYDROXYZINE; ICATIBANT; RANITIDINE; RUPATADINE; TRANEXAMIC ACID; TRYPTASE;

ADULT; ANGIONEUROTIC EDEMA; CASE REPORT; DETERIORATION; DRUG EFFICACY; DRUG INDUCED HEADACHE; DRUG WITHDRAWAL; ERYTHEMA; FACE; FEMALE; FOOT EDEMA; GLOTTIS; HEART PALPITATION; HUMAN; JOB STRESS; LETTER; MENINGISM; PAIN; PETECHIA; PHARYNX DISEASE; RECURRENT DISEASE; RECURRENT IDIOPATHIC ANGIOEDEMA; VOMITING;

ADULT; ANGIOEDEMA; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; BRADYKININ; FEMALE; HUMANS;

EID: 84871346685     PISSN: 10189068     EISSN: 16980808     Source Type: Journal    
DOI: None     Document Type: Letter

References (10)

1. Zingale LC, Beltrami L, Zanichelli A, Maggioni L, Pappalardo E, Cicardi B, Cicardi M. Angioedema without urticaria: a large clinical survey. CMAJ. 2006;175(9):1065-70.
2. Bouillet L, Ponard D, Drouet C, Massot C. Non-histaminic angiodema management: diagnostic and therapeutic interest of tranexamic acid. Rev Med Interne. 2004;25(12):924-6. French.
3. Bork K. Hereditary angioedema with normal C1 inhibitor activity including hereditary angioedema with coagulation factor XII gene mutations. Immunol Allergy Clin North Am. 2006;26(4):709-24.
4. Duan QL, Binkley K, Rouleau GA. Genetic analysis of Factor XII and bradykinin catabolic enzymes in a family with estrogen- dependent inherited angioedema. J Allergy Clin Immunol. 2009;123(4):906-10.
5. Agostoni A, Cicardi M. Drug-induced angioedema without urticaria. Drug Saf. 2001;24(8):599-606.
6. Frigas E, Park M. Idiopathic recurrent angioedema. Immunol Allergy Clin North Am. 2006;26(4):739-51.
7. Gruber BL, Baeza ML, Marchese MJ, Agnello V, Kaplan AP. Prevalence and functional role of anti-IgE autoantibodies in urticarial syndromes. J Invest Dermatol. 1988;90(2):213-7.
8. Hide M, Francis DM, Grattan CE, Hakimi J, Kochan J P, Greaves MW. Autoantibodies against the high-affi nity IgE receptor as a cause of histamine release in chronic urticaria. N Engl J Med. 1993;328(22):1599-604.
9. European Public Assessment Report (EMEA/350457/2008) for Firazyr (icatibant). Available from: http://www.ema.europa.eu/ema. 2008. Updated 14th July 2009.
10. Deeks ED. Icatibant. Drugs. 2010;70(1):73-81.